Kelderman, Sander <br/><br/>
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Nov 2013 
 - 1786-8 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2013.786839  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Monoclonal--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Immunotherapy<br/>Ipilimumab<br/>Melanoma--drug therapy<br/>Neoplasm Staging<br/>Netherlands<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Uveal Neoplasms--drug therapy<br/>Uveal Melanoma